Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- UNCY
- Price
- 0.55
- Stock movement up
- +0.02 (3.30%)
- Company name
- Unicycive Therapeutics Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 56.84M
- Ent value
- 35.22M
- Price/Sales
- -
- Price/Book
- 2.04
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -8.97%
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -57.88%
- 3 year return
- -24.25%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-04-12
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
UNCY does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 2.04 |
| EV to Sales | -129.95 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 103.80M |
| EPS (TTM) | -0.33 |
| FCF per share (TTM) | -0.30 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | -271.00K |
| Gross profit (TTM) | -637.00K |
| Operating income (TTM) | -29.17M |
| Net income (TTM) | -28.93M |
| EPS (TTM) | -0.33 |
| EPS (1y forward) | -0.34 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 235.06% |
| Operating margin (TTM) | 10763.47% |
| Profit margin (TTM) | 10674.17% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 32.35M |
| Net receivables | 0.00 |
| Total current assets | 37.74M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 38.57M |
| Accounts payable | 548.00K |
| Short/Current long term debt | 807.00K |
| Total current liabilities | 10.46M |
| Total liabilities | 10.72M |
| Shareholder's equity | 27.85M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -26.47M |
| Capital expenditures (TTM) | 50.00K |
| Free cash flow (TTM) | -26.52M |
| Dividends paid (TTM) | 2.38M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -103.87% |
| Return on Assets | -74.99% |
| Return on Invested Capital | -101.88% |
| Cash Return on Invested Capital | -93.39% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.53 |
| Daily high | 0.57 |
| Daily low | 0.50 |
| Daily Volume | 879K |
| All-time high | 3.80 |
| 1y analyst estimate | 5.50 |
| Beta | 2.29 |
| EPS (TTM) | -0.33 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| UNCY | S&P500 | |
| Current price drop from All-time high | -85.59% | -12.89% |
| Highest price drop | -93.79% | -56.47% |
| Date of highest drop | 13 Aug 2024 | 9 Mar 2009 |
| Avg drop from high | -70.54% | -11.07% |
| Avg time to new high | 943 days | 12 days |
| Max time to new high | 942 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
56.84M
Marketcap category
Small-cap
Description
Unicycive Therapeutics, Inc., a biotechnology company, develops treatments for various medical conditions in the United States. Its drug candidates include UNI 494, a pro-drug of Nicorandil that is being developed as a treatment for acute kidney injury; and Renazorb (Oxylanthanum Carbonate), which is being developed for the treatment of hyperphosphatemia in patients with chronic kidney disease. Unicycive Therapeutics, Inc. has license agreements with Shilpa Medicare Ltd; Sphaera Pharma Pte. Ltd.; Syneos Health LLC; Inotiv; Lee's Pharmaceutical (HK) Limited; Celerion; and Lotus International Pte Ltd. The company was incorporated in 2016 and is based in Los Altos, California.
Employees
14
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page